v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (30,471) $ (26,708)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 3,861 3,981
Depreciation on property and equipment 26 10
Foreign currency translation adjustments 571 26
Non-cash lease expense 274 152
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 3,039 2,668
Accounts payable 675 6,811
Accrued expenses 1,171 (597)
Operating lease liabilities (360) (141)
Net cash used in operating activities (21,214) (13,798)
Cash flows from investing activities    
Purchase of property and equipment (18) (47)
Net cash used in investing activities (18) (47)
Cash flows from financing activities    
Capital contributions 91 164
Proceeds from stock options exercised 0 63
Payment of deferred offering costs 0 (602)
Net cash provided by financing activities 91 193,553
Net change in cash (21,141) 179,708
Cash – beginning of period 400,146 100,571
Cash – end of period 379,005 280,279
Underwritten Public Offering    
Cash flows from financing activities    
Proceeds from issuance of common stock 0 131,030
Warrant Redemption    
Cash flows from financing activities    
Proceeds from issuance of common stock 0 65,752
Roivant Sciences Ltd. (RSL)    
Cash flows from financing activities    
Repayment of note payable to Roivant Sciences Ltd. $ 0 $ (2,854)

Source